Titan Intl SEC Filings

Max Narancich, Chief Operating Officer of Carlstar at Titan International (TWI), reported insider trading activity on June 20, 2025. The transaction involved the disposition of 1,461 shares of common stock at a price of $9.325 per share through a tax withholding transaction (Code F) related to the vesting of restricted stock.

Following the transaction, Narancich holds 51,539 shares directly, including 47,000 restricted stock shares with the following vesting schedule:

• 11,666 shares vesting on March 10, 2026
• 6,000 shares vesting on June 20, 2026
• 11,667 shares vesting on March 10, 2027
• 6,000 shares vesting on June 20, 2027
• 11,667 shares vesting on March 10, 2028

This Form 4 filing represents a routine transaction where shares were withheld by the company to cover tax obligations from vesting restricted stock, rather than an open market sale by the insider.

Form 4 highlights for Titan International (TWI): VP & Chief Accounting Officer Anthony Eheli sold 25,000 common shares on 06/20/2025 under transaction code S (sale). The weighted-average price was $9.24, with individual trades executed between $9.14 and $9.33.

After the sale, Eheli’s direct beneficial ownership stands at 45,276 shares, of which 43,334 are unvested restricted shares scheduled to vest 14,166 on 03/10/2026, 6,667 on 03/14/2026, 14,167 on 03/10/2027, and 8,334 on 03/10/2028. No derivative securities were reported.

The disposal represents roughly one-third of Eheli’s pre-transaction stake and generated proceeds of about $231k. No 10b5-1 trading plan box is ticked, suggesting the sale was not executed under a pre-arranged plan. There are no indications of additional insider sales or purchases by other executives in this filing.

Titan International, Inc. (TWI) filed a Form 144 indicating a planned sale of 25,000 common shares through broker Merrill Lynch, 1630 S Lindbergh Blvd, Frontenac, MO 63131. The shares have an aggregate market value of $230,000, implying an estimated transaction price of roughly $9.20 per share. The proposed sale date is 20 June 2025 on the NASDAQ.

The securities were acquired on 10 March 2025 via a stock-option exercise for the same 25,000-share amount. No other sales by the reporting person have occurred in the past three months, and the filing affirms the signer’s lack of undisclosed adverse information about the issuer.

Given Titan’s reported 63,704,208 shares outstanding, the planned disposition represents approximately 0.04 % of total shares—a de-minimis level that is unlikely to affect liquidity or control. Form 144 filings signal intent rather than execution; actual sales may differ in timing or volume.

Investors typically monitor such notices for insight into insider sentiment, but the modest size relative to Titan’s float suggests limited market impact barring additional, larger disposals.

Anthony L. Soave, Director at Titan International, reported significant insider transactions on June 16, 2025. Key details include:

• Acquired 19,780 Restricted Stock Units (RSUs) at $0, which vest on the first anniversary of the grant date
• Currently holds 1,168,623 shares of common stock directly
• Maintains indirect ownership of 5,000 shares through Brambleton Investments LLC
• Holds three sets of stock options: - 20,000 shares at $6.995 (expires 6/7/2026) - 20,000 shares at $11.79 (expires 6/14/2027) - 20,000 shares at $11.845 (expires 6/13/2028)

This transaction represents a significant equity award to a board member, indicating continued alignment with shareholder interests. The director's total beneficial ownership, including direct holdings, indirect ownership, and outstanding options, demonstrates substantial investment in the company.

Maurice M. Taylor Jr., Director of Titan International (TWI), reported significant insider transactions on Form 4. On June 16, 2025, Taylor acquired 19,780 Restricted Stock Units (RSUs) at $0, which will vest one year from the grant date. Following this transaction, Taylor directly owns 652,631 shares of common stock.

The filing also discloses Taylor's existing derivative securities holdings, including:

• 29,200 stock options with exercise price of $11.79, exercisable from June 14, 2017 to June 14, 2027
• 20,000 stock options with exercise price of $11.845, exercisable from June 13, 2018 to June 13, 2028

This equity-based compensation grant demonstrates the company's continued commitment to aligning director interests with shareholders through long-term incentive awards.